Medtronic received information that 3 years and 5 months post implant of this 22mm pulmonary bioprosthetic valved conduit, balloon valvuloplasty was performed due to moderate stenosis.Post valvuloplasty, pulmonary insufficiency was present.Then, 4 years and 2 months post implant of the pulmonary bioprosthetic valved conduit, cardiac magnetic resonance imaging (mri) revealed moderate stenosis redeveloped and elevated right ventricle (rv) pressures.It was reported the patient was symptomatic with increasing fatigue.Ultimately, 5 years post implant, an 18mm transcatheter pulmonary bioprosthetic valve (tpbv) was implanted valve-in-valve.No additional adverse patient effects were reported. .
|